RSI společnosti AC Immune SA
Jaká je hodnota metriky RSI společnosti AC Immune SA?
Hodnota metriky RSI společnosti AC Immune SA je 38.74
Jaká je definice metriky RSI?
Index relativní síly (Relative strength index - RSI 14) je technický ukazatel, který se řadí mezi momentum indikátory a měří rychlost a změnu ceny. Jeho hodnota se pohybuje mezi 0 a 100 a používá se k charakterizování překupovaného a přeprodaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností AC Immune SA
Čemu se věnuje společnost AC Immune SA?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Firmy s metrikou rsi podobnou společnosti AC Immune SA
- Hodnota metriky RSI společnosti ECMOHO Ltd je 38.72
- Hodnota metriky RSI společnosti People`s United Inc je 38.73
- Hodnota metriky RSI společnosti Inventure Growth & Securities je 38.73
- Hodnota metriky RSI společnosti GoHealth je 38.73
- Hodnota metriky RSI společnosti Crescita Therapeutics je 38.73
- Hodnota metriky RSI společnosti Novonix je 38.73
- Hodnota metriky RSI společnosti AC Immune SA je 38.74
- Hodnota metriky RSI společnosti CMC Metals je 38.75
- Hodnota metriky RSI společnosti New Century Hong Kong je 38.75
- Hodnota metriky RSI společnosti Sievi Capital Oyj je 38.75
- Hodnota metriky RSI společnosti Discovery Inc je 38.75
- Hodnota metriky RSI společnosti Landis+Gyr AG je 38.75
- Hodnota metriky RSI společnosti Sang Hing Hldg (Intl) Ltd je 38.75